Abbott Aims To Quash Bayer Subpoena

Law360, New York (July 19, 2007, 12:00 AM EDT) -- Abbott Diabetes Care Inc. and parent Abbott Laboratories have called on a federal court to quash Bayer HealthCare LLC’s subpoena demanding information from a patent settlement that is alleged to be relevant to this case over glucose testing devices.

Abbott asked the U.S. District Court for the Northern District of California on Thursday to either invalidate Bayer’s subpoena or issue a protective order, claiming that the subpoena overlapped with Roche Diagnostics Operations Inc. and Bayer’s joint motion to compel Abbott to produce the same settlement agreement...
To view the full article, register now.